Evidence map›Paper›PMID 37007592›Full record

ArticleJournal of vitreoretinal diseases

A History of Anti-VEGF Inhibitors in the Ophthalmic Literature: A Bibliographic Review.

Todd D Whitescarver, Samuel D Hobbs, Christian I Wade, Jordan W Winegar, Marcus H Colyer, Ashvini K Reddy, Paul M Drayna, Grant A Justin

Abstract read
In one paragraph

Article in Journal of vitreoretinal diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Wound Modulations in Glaucoma Surgery: A Systematic Review.Bioengineering (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Todd D WhitescarverDepartment of Ophthalmology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Samuel D HobbsDepartment of Ophthalmology, Wilford Hall Eye Center, San Antonio, TX, USA.
Christian I WadeSchool of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Jordan W WinegarDepartment of Ophthalmology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Marcus H ColyerDepartment of Ophthalmology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Ashvini K ReddyDepartment of Ophthalmology, University of Texas Health Science Center, San Antonio, TX, USA.
Paul M DraynaDepartment of Ophthalmology, Wilford Hall Eye Center, San Antonio, TX, USA.
Grant A JustinDepartment of Ophthalmology, Walter Reed National Military Medical Center, Bethesda, MD, USA.ORCID https://orcid.org/0000-0001-6084-6399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This work aimed to analyze the 100 most-cited articles on antivascular endothelial growth factor (anti-VEGF) inhibitors. Methods: A literature search for anti-VEGF inhibitors using the Web of Science was completed using the bibliographic databases for peer-reviewed literature published in Results: There were 42 696 cumulative citations among the top 100 articles. The articles were published between 2004 to 2016, with most articles published in 2006. Conclusions: As evidenced by the considerable number of citations accumulated over the past 20 years, anti-VEGF inhibitors have led to significant research in ophthalmology.

Indexed as

anti-VEGF agentsbranch retinal vein occlusiondiabetic macular edemamacular edema

Identifiers

PMID37007592
PMCPMC9976233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.